table of content
1 Study Coverage
1.1 Tumor Necrosis Factor (TNF) Inhibitor Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Remicade
1.2.3 Humira
1.2.4 Cimzia
1.2.5 Simponi
1.2.6 Others
1.3 Market by Application
1.3.1 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Online Pharmacies
1.3.3 Specialty Pharmacies
1.3.4 Hospital Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales by Region
2.4.1 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Tumor Necrosis Factor (TNF) Inhibitor Drugs by Region (2023-2028)
2.5 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue by Region
2.5.1 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue by Region (2017-2022)
2.5.2 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales by Manufacturers
3.1.1 Global Top Tumor Necrosis Factor (TNF) Inhibitor Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Tumor Necrosis Factor (TNF) Inhibitor Drugs in 2021
3.2 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue by Manufacturers
3.2.1 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue in 2021
3.3 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales by Type
4.1.1 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales Market Share by Type (2017-2028)
4.2 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue by Type
4.2.1 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Price by Type
4.3.1 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Price by Type (2017-2022)
4.3.2 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales by Application
5.1.1 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales Market Share by Application (2017-2028)
5.2 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue by Application
5.2.1 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Price by Application
5.3.1 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Price by Application (2017-2022)
5.3.2 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Type
6.1.1 North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales by Type (2017-2028)
6.1.2 North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue by Type (2017-2028)
6.2 North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Application
6.2.1 North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales by Application (2017-2028)
6.2.2 North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue by Application (2017-2028)
6.3 North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Country
6.3.1 North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales by Country (2017-2028)
6.3.2 North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Type
7.1.1 Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales by Type (2017-2028)
7.1.2 Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue by Type (2017-2028)
7.2 Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Application
7.2.1 Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales by Application (2017-2028)
7.2.2 Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue by Application (2017-2028)
7.3 Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Country
7.3.1 Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales by Country (2017-2028)
7.3.2 Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Type
8.1.1 Asia Pacific Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Application
8.2.1 Asia Pacific Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Region
8.3.1 Asia Pacific Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Type
9.1.1 Latin America Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales by Type (2017-2028)
9.1.2 Latin America Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue by Type (2017-2028)
9.2 Latin America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Application
9.2.1 Latin America Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales by Application (2017-2028)
9.2.2 Latin America Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue by Application (2017-2028)
9.3 Latin America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Country
9.3.1 Latin America Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales by Country (2017-2028)
9.3.2 Latin America Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Type
10.1.1 Middle East and Africa Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Application
10.2.1 Middle East and Africa Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Country
10.3.1 Middle East and Africa Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Takeda Pharmaceuticals
11.1.1 Takeda Pharmaceuticals Corporation Information
11.1.2 Takeda Pharmaceuticals Overview
11.1.3 Takeda Pharmaceuticals Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Takeda Pharmaceuticals Tumor Necrosis Factor (TNF) Inhibitor Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Takeda Pharmaceuticals Recent Developments
11.2 Amgen
11.2.1 Amgen Corporation Information
11.2.2 Amgen Overview
11.2.3 Amgen Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Amgen Tumor Necrosis Factor (TNF) Inhibitor Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Amgen Recent Developments
11.3 AbbVie
11.3.1 AbbVie Corporation Information
11.3.2 AbbVie Overview
11.3.3 AbbVie Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 AbbVie Tumor Necrosis Factor (TNF) Inhibitor Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 AbbVie Recent Developments
11.4 Pfizer
11.4.1 Pfizer Corporation Information
11.4.2 Pfizer Overview
11.4.3 Pfizer Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Pfizer Tumor Necrosis Factor (TNF) Inhibitor Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Pfizer Recent Developments
11.5 Novartis
11.5.1 Novartis Corporation Information
11.5.2 Novartis Overview
11.5.3 Novartis Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Novartis Tumor Necrosis Factor (TNF) Inhibitor Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Novartis Recent Developments
11.6 Johnson and Johnson
11.6.1 Johnson and Johnson Corporation Information
11.6.2 Johnson and Johnson Overview
11.6.3 Johnson and Johnson Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Johnson and Johnson Tumor Necrosis Factor (TNF) Inhibitor Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Johnson and Johnson Recent Developments
11.7 UCB
11.7.1 UCB Corporation Information
11.7.2 UCB Overview
11.7.3 UCB Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 UCB Tumor Necrosis Factor (TNF) Inhibitor Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 UCB Recent Developments
11.8 Merck
11.8.1 Merck Corporation Information
11.8.2 Merck Overview
11.8.3 Merck Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Merck Tumor Necrosis Factor (TNF) Inhibitor Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Merck Recent Developments
11.9 Abbott Laboratories
11.9.1 Abbott Laboratories Corporation Information
11.9.2 Abbott Laboratories Overview
11.9.3 Abbott Laboratories Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Abbott Laboratories Tumor Necrosis Factor (TNF) Inhibitor Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Abbott Laboratories Recent Developments
11.10 Biogen
11.10.1 Biogen Corporation Information
11.10.2 Biogen Overview
11.10.3 Biogen Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Biogen Tumor Necrosis Factor (TNF) Inhibitor Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Biogen Recent Developments
11.11 Gilead Sciences
11.11.1 Gilead Sciences Corporation Information
11.11.2 Gilead Sciences Overview
11.11.3 Gilead Sciences Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Gilead Sciences Tumor Necrosis Factor (TNF) Inhibitor Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Gilead Sciences Recent Developments
11.12 Thermo Fisher Scientific
11.12.1 Thermo Fisher Scientific Corporation Information
11.12.2 Thermo Fisher Scientific Overview
11.12.3 Thermo Fisher Scientific Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Thermo Fisher Scientific Tumor Necrosis Factor (TNF) Inhibitor Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Thermo Fisher Scientific Recent Developments
11.13 Bristol-Myers Squibb
11.13.1 Bristol-Myers Squibb Corporation Information
11.13.2 Bristol-Myers Squibb Overview
11.13.3 Bristol-Myers Squibb Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Bristol-Myers Squibb Tumor Necrosis Factor (TNF) Inhibitor Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Bristol-Myers Squibb Recent Developments
11.14 Astellas Pharma
11.14.1 Astellas Pharma Corporation Information
11.14.2 Astellas Pharma Overview
11.14.3 Astellas Pharma Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Astellas Pharma Tumor Necrosis Factor (TNF) Inhibitor Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Astellas Pharma Recent Developments
11.15 AstraZeneca
11.15.1 AstraZeneca Corporation Information
11.15.2 AstraZeneca Overview
11.15.3 AstraZeneca Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 AstraZeneca Tumor Necrosis Factor (TNF) Inhibitor Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 AstraZeneca Recent Developments
11.16 Eli Lilly and Company
11.16.1 Eli Lilly and Company Corporation Information
11.16.2 Eli Lilly and Company Overview
11.16.3 Eli Lilly and Company Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Eli Lilly and Company Tumor Necrosis Factor (TNF) Inhibitor Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Eli Lilly and Company Recent Developments
11.17 Roche
11.17.1 Roche Corporation Information
11.17.2 Roche Overview
11.17.3 Roche Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Roche Tumor Necrosis Factor (TNF) Inhibitor Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Roche Recent Developments
11.18 Sanofi
11.18.1 Sanofi Corporation Information
11.18.2 Sanofi Overview
11.18.3 Sanofi Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Sanofi Tumor Necrosis Factor (TNF) Inhibitor Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Sanofi Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Tumor Necrosis Factor (TNF) Inhibitor Drugs Industry Chain Analysis
12.2 Tumor Necrosis Factor (TNF) Inhibitor Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Tumor Necrosis Factor (TNF) Inhibitor Drugs Production Mode & Process
12.4 Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales and Marketing
12.4.1 Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales Channels
12.4.2 Tumor Necrosis Factor (TNF) Inhibitor Drugs Distributors
12.5 Tumor Necrosis Factor (TNF) Inhibitor Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Tumor Necrosis Factor (TNF) Inhibitor Drugs Industry Trends
13.2 Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Drivers
13.3 Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Challenges
13.4 Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Restraints
14 Key Findings in The Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
